Trademark Overview
On Thursday, April 27, 2023, a trademark application was filed for ERVACCINE with the United States Patent and Trademark Office. The USPTO has given the ERVACCINE trademark a serial number of 97909881. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, August 9, 2024. This trademark is owned by Ervaccine Technologies. The ERVACCINE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for the treatment of cancer; therapeutic vaccines; Medical preparations, namely, T-cell therapy preparations for the treatment of cancer; stem cells for medical use; biological preparations for the prevention and treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of cancer; chemical preparations for medical purposes, namely, for the prevention or treatment of cancer; diagnostic preparations for medical purposes; medicinal preparations for the treatment of infectious diseases and for use in immunotherapy and oncology
Medical and surgical services in the field of immunotherapy and oncology; medical diagnosis in the field of oncology, namely, medical diagnosis of cancer; medical testing for diagnostic or treatment purposes; provision of medical information in the field of immunotherapy and oncology; medical analysis for the diagnosis and treatment of persons; genetic testing services for medical purposes
Medical research laboratory services; biotechnological and pharmaceutical drug research and development services; pharmaceutical and biotechnological research and development; provision of medical and scientific research information in the field of pharmaceuticals; provision of medical and scientific research information in the field of therapeutic vaccines; provision of medical and scientific research information in the field of oncology, immunotherapy, stem cell therapy, and T-cell therapy; Providing medical and scientific research information in the field of clinical trials; screening and selection of molecules for scientific and pharmacological research purposes, not for medical purposes; research and development in the field of immunotherapy